MSWM
IBB icon

McGlone Suttner Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

McGlone Suttner Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-115
Closed -$15.6K – 466
2023
Q4 		$15.6K Buy
+115
New +$14K ﹤0.01% 471

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

McGlone Suttner Wealth Management's IBB Position: Q1 2024 in Review

McGlone Suttner Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 115 shares — an estimated $15.6K sold.

McGlone Suttner Wealth Management first reported a position in IBB in Q4 2023 and held it in 1 quarter. The position peaked at $15.6K in Q4 2023. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • McGlone Suttner Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 115 iShares Biotechnology ETF shares in Q1 2024, an estimated $15.6K.
  • McGlone Suttner Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 1 quarter.
  • McGlone Suttner Wealth Management's iShares Biotechnology ETF position peaked at $15.6K in Q4 2023.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.